ONCY Earnings Date: Nov 11, 2026 (Estimated) — Oncolytics Biotech Inc.
NASDAQ
Updated
When is ONCY's next earnings date?
Oncolytics Biotech Inc. (ONCY) is expected to report Q3 2026 earnings on Wednesday, November 11, 2026 at 5:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.05.
How did ONCY do in its last earnings report?
In its most recent report on Aug 12, 2026 (Q2 2026), Oncolytics Biotech Inc. posted EPS of -$0.08 versus the -$0.05 estimate, a miss of 14.3%. Revenue was $0. The stock's 1-day post-earnings move was +0.5%.
How much does ONCY stock move after earnings?
ONCY beat EPS estimates in 3 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 3.7% (up or down) in the day after earnings.
About Oncolytics Biotech Inc.
Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments. The company develops pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative advanced and metastatic breast cancer, metastatic pancreatic ductal adenocarcinoma, and anal cancer. It has an agreement with Roche Holding AG to supply its immune checkpoint inhibitors, atezolizumab, for use in its ongoing sponsored studies. Oncolytics Biotech Inc. was incorporated in 1998 and is headquartered in Calgary, Canada.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-12 | Q2 2026 | -0.05 | -0.08 | -14.29% | $0 | ❌ Miss | +0.45% | +3.02% | -5.85% |
| 2026-05-14 | Q1 2026 | -0.07 | -0.06 | +14.29% | $0 | ✅ Beat | -2.62% | -9.50% | -2.60% |
| 2026-03-30 | Q4 2025 | -0.07 | -0.09 | -28.57% | $0 | ❌ Miss | -4.17% | +13.10% | +7.19% |
| 2025-11-12 | Q3 2025 | -0.06 | -0.10 | -66.67% | $0 | ❌ Miss | -4.85% | -8.37% | -12.50% |
| 2025-08-08 | Q2 2025 | -0.11 | -0.05 | +54.55% | $0 | ✅ Beat | -6.20% | +2.75% | +39.88% |
| 2025-03-07 | Q4 2024 | -0.08 | -0.07 | +12.50% | $0 | ✅ Beat | -6.29% | -15.24% | -32.63% |
| 2024-11-12 | Q3 2024 | -0.07 | -0.09 | -28.57% | $0 | ❌ Miss | +3.70% | -7.87% | -20.95% |
| 2024-08-01 | Q2 2024 | -0.07 | -0.07 | +0.00% | $0 | ➖ Inline | -0.97% | -4.30% | -6.89% |
Showing last 8 quarters.